Monument Capital Management Eli Lilly & CO Transaction History

Monument Capital Management

$358 Million
Q3 2024

A detailed history of Monument Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Monument Capital Management holds 2,829 shares of LLY stock, worth $2.13 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

2,829

Previous 2,842 0.46%

Holding current value

$2.13 Million

Previous $2.57 Million 2.6%

% of portfolio

0.7%

Previous 0.78%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$772.14 - $960.02 $10,037 - $12,480	-13 Reduced 0.46%	2,829 $2.51 Million
Q2 2024 Jul 19, 2024	SELL	$724.87 - $909.04 $53,640 - $67,268	-74 Reduced 2.54%	2,842 $2.57 Million
Q1 2024 Apr 18, 2024	BUY	$592.2 - $792.28 $22,503 - $30,106	38 Added 1.32%	2,916 $2.27 Million
Q4 2023 Feb 01, 2024	BUY	$525.19 - $619.13 $40,964 - $48,292	78 Added 2.79%	2,878 $1.68 Million
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $9,128 - $12,585	21 Added 0.76%	2,800 $1.5 Million
Q2 2023 Jul 18, 2023	BUY	$350.74 - $468.98 $57,872 - $77,381	165 Added 6.31%	2,779 $1.3 Million
Q1 2023 Apr 21, 2023	SELL	$310.63 - $364.82 $70,823 - $83,178	-228 Reduced 8.02%	2,614 $897,000
Q4 2022 Jan 26, 2023	BUY	$321.55 - $374.67 $76,850 - $89,546	239 Added 9.18%	2,842 $0
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $298,851 - $340,572	-1,008 Reduced 27.91%	2,603 $842,000
Q2 2022 Jul 20, 2022	BUY	$278.73 - $327.27 $108,147 - $126,980	388 Added 12.04%	3,611 $1.17 Million
Q1 2022 Apr 14, 2022	BUY	$234.69 - $291.66 $234,690 - $291,660	1,000 Added 44.98%	3,223 $923,000
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $23,834 - $29,578	106 Added 5.01%	2,223 $614,000
Q3 2021 Oct 22, 2021	BUY	$221.6 - $272.71 $9,972 - $12,271	45 Added 2.17%	2,117 $489,000
Q2 2021 Jul 27, 2021	BUY	$180.55 - $233.54 $73,122 - $94,583	405 Added 24.3%	2,072 $476,000
Q1 2021 Apr 12, 2021	SELL	$164.32 - $212.72 $2.35 Million - $3.04 Million	-14,307 Reduced 89.56%	1,667 $311,000
Q4 2020 Jan 15, 2021	BUY	$130.46 - $172.63 $79,580 - $105,304	610 Added 3.97%	15,974 $2.7 Million
Q3 2020 Oct 23, 2020	SELL	$146.22 - $169.13 $47,667 - $55,136	-326 Reduced 2.08%	15,364 $2.27 Million
Q2 2020 Jul 16, 2020	SELL	$136.42 - $164.18 $136,829 - $164,672	-1,003 Reduced 6.01%	15,690 $2.58 Million
Q1 2020 Apr 14, 2020	BUY	$119.05 - $147.35 $18,809 - $23,281	158 Added 0.96%	16,693 $2.32 Million
Q4 2019 Jan 14, 2020	BUY	$106.92 - $132.43 $8,019 - $9,932	75 Added 0.46%	16,535 $2.17 Million
Q3 2019 Oct 21, 2019	SELL	$106.79 - $116.16 $51,259 - $55,756	-480 Reduced 2.83%	16,460 $1.84 Million
Q2 2019 Jul 23, 2019	SELL	$110.79 - $129.32 $38,333 - $44,744	-346 Reduced 2.0%	16,940 $1.91 Million
Q1 2019 Apr 10, 2019	SELL	$111.31 - $131.02 $89,827 - $105,733	-807 Reduced 4.46%	17,286 $2.24 Million
Q4 2018 Jan 15, 2019	BUY	$105.9 - $118.64 $1.84 Million - $2.06 Million	17,380 Added 2437.59%	18,093 $2.09 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $61,218 - $76,512	713 New	713 $77,000
Q3 2018 Oct 11, 2018	SELL	$85.86 - $107.31 $44,046 - $55,050	-513 Closed	0 $0
Q4 2017 Feb 05, 2018	BUY	$81.94 - $87.89 $42,035 - $45,087	513	513 $43,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Monument Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Monument Capital Management with notifications on news.

Account

Monument Capital Management Eli Lilly & CO Transaction History